Zanzalintinib as Cabozantinib's Successor: The Case for Skepticism
Fields of Study & Subjects
Lung Cancer Treatments and Mutations
Melanoma and MAPK Pathways
Chronic Myeloid Leukemia Treatments
Publication details
- Journal / source
- JCO oncology advances.
- Publisher
- American Society of Clinical Oncology (ASCO)
- Volume
- 3
- Issue
- 1
- Publication date
- 1 January 2026
- Language
- EN